- FROM THE ANALYST'S COUCH
Infectious disease vaccines
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 18, 169-170 (2019)
doi: https://doi.org/10.1038/d41573-018-00011-6
Acknowledgements
We are grateful to D. Thomas, C. Wessel and P. Arthur of the Biotechnology Innovation Organization for their critical review of the data, use of figures and their critical review of this manuscript.
Disclaimer
The opinions expressed in this manuscript are those of the authors and not intended to represent the opinions of the National Vaccine Program Office and the National Vaccine Advisory Committee.
Supplementary Information
Competing Interests
M.T.C. is an employee and shareholder of Ology Bioservices, and a board member, consultant and shareholder of NovaDigm Therapeutics. A.K.S. declares no competing interests.